Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 5
Date: April 16, 2026Time: 11-12pm EDT / 5-6pm CEST Title: Development of an N=1 Therapeutic Antisense Oligonucleotide for a unique UNC13A variant Description: Rare disorders collectively affect 3 to 10% of the population, but treatment options are scarce. Recently, genetic variants ...
Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modifications
Date: April 2, 2026Time: 11-12pm EDT / 5-6pm CEST Title: Extended Nucleic Acid Therapeutics: Unlocking potential through tiny methylene chemical modifications Description: Modulation of the backbone structures of oligonucleotides has a profound impact on the pharmacokinetics and pharmacodynamics of RNA medicines. ...
Advancing Prime Editing–Based Genome Editing Technologies for Therapeutic Applications
Date: March 26, 2026 Time: 12-1pm EDT / 5-6pm CET Title: Advancing Prime Editing–Based Genome Editing Technologies for Therapeutic Applications Description: In this webinar, I will discuss recent advances in prime editing–based genome engineering, including split prime editing, template-jumping prime editing, ...
Meet the 2026 Trainee Reps
Date: March 19, 2026Time: 12-1pm EDT / 5-6pm CET Title: A Trainee's Perspective: Advocacy & Research in ALS Description: In this talk, Daniel will introduce himself as one of the two newest trainee representatives on the OTS Board of Directors by ...
Trainee Spotlight Series: 2025 Oligo Meeting Poster Winners 4
Date: March 12, 2026 Time: 12-1pm EDT / 5-6pm CET Title: Neonatal Delivery of Exon Skipping Therapeutics Maximizes Brain Dystrophin Rescue in the Mdx52 Mouse Model of DMD Description: In this webinar, I will explore how early-life exon-skipping strategies can be ...
